Clorox (CLX) Financials

$134.96 -3.43 (-2.48%)

Closing price 03:59 PM Eastern

Extended Trading

$135.17 +0.21 (+0.15%)

As of 07:58 PM Eastern

Annual Income Statements for Clorox

This table shows Clorox's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024
Net Income / (Loss) Attributable to Common Shareholders	5,629	648	701	823	820	939	710	462	149	280
Consolidated Net Income / (Loss)	580	648	701	823	820	939	719	471	161	292
Net Income / (Loss) Continuing Operations	606	648	703	823	820	939	719	471	161	292
Total Pre-Tax Income	0.00	983	1,033	1,054	1,024	1,185	900	607	238	398
Total Operating Income	5,655	1,064	1,127	1,136	1,124	1,274	927	750	408	683
Total Gross Profit	2,465	2,598	2,671	2,675	2,728	3,063	3,199	2,545	2,908	3,048
Total Revenue	5,655	5,761	5,973	6,124	6,214	6,721	7,341	7,107	7,389	7,093
Operating Revenue	5,655	5,761	5,973	6,124	6,214	6,721	7,341	7,107	7,389	7,093
Total Cost of Revenue	0.00	3,163	3,302	3,449	3,486	3,658	4,142	4,562	4,481	4,045
Operating Cost of Revenue	0.00	3,163	3,302	3,449	3,486	3,658	4,142	4,562	4,481	4,045
Total Operating Expenses	0.00	1,534	1,544	1,539	1,604	1,789	2,272	1,795	2,500	2,365
Selling, General & Admin Expense	0.00	806	810	837	856	969	1,004	954	1,183	1,167
Marketing Expense	0.00	587	599	570	612	675	790	709	734	832
Research & Development Expense	0.00	141	135	132	136	145	149	132	138	126
Impairment Charge	-	-	-	-	0.00	0.00	329	0.00	445	0.00
Other Special Charges / (Income)	-	-	-	-	-	-	-	0.00	0.00	240
Total Other Income / (Expense), net	0.00	-81	-94	-82	-100	-89	-27	-143	-170	-285
Interest Expense	0.00	88	88	85	97	99	99	106	90	90
Other Income / (Expense), net	0.00	7.00	-6.00	3.00	-3.00	10	72	-37	-80	-195
Income Tax Expense	0.00	335	330	231	204	246	181	136	77	106
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	-	0.00	0.00	9.00	9.00	12	12
Basic Earnings per Share	$0.00	$5.01	$5.43	$6.37	$6.42	$7.46	$5.66	$3.75	$1.21	$2.26
Weighted Average Basic Shares Outstanding	0.00	129.47M	128.95M	129.29M	127.73M	125.83M	125.57M	123.11M	123.59M	124.17M
Diluted Earnings per Share	$0.00	$4.92	$5.33	$6.26	$6.32	$7.36	$5.58	$3.73	$1.20	$2.25
Weighted Average Diluted Shares Outstanding	0.00	131.72M	131.57M	131.58M	129.79M	127.67M	127.30M	123.91M	124.18M	124.80M
Weighted Average Basic & Diluted Shares Outstanding	130.30M	129.30M	129.10M	129.20M	127.70M	126.21M	122.81M	123.16M	123.83M	123.86M
Cash Dividends to Common per Share	$2.99	$3.08	$3.20	$3.48	$3.84	$4.24	$4.44	$4.64	$4.72	$4.80

This table shows Clorox's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	101	85	99	-211	176	22	93	-51	216	99	193
Consolidated Net Income / (Loss)	104	87	102	-209	181	25	96	-50	221	103	194
Net Income / (Loss) Continuing Operations	104	87	102	-209	181	25	96	-50	221	103	194
Total Pre-Tax Income	129	116	130	-245	237	29	136	-42	275	177	237
Total Operating Income	183	172	149	-197	284	62	326	-22	317	176	236
Total Gross Profit	668	626	620	800	862	532	866	766	884	807	738
Total Revenue	1,801	1,740	1,715	1,915	2,019	1,386	1,990	1,814	1,903	1,762	1,686
Operating Revenue	1,801	1,740	1,715	1,915	2,019	1,386	1,990	1,814	1,903	1,762	1,686
Total Cost of Revenue	1,133	1,114	1,095	1,115	1,157	854	1,124	1,048	1,019	955	948
Operating Cost of Revenue	1,133	1,114	1,095	1,115	1,157	854	1,124	1,048	1,019	955	948
Total Operating Expenses	485	454	471	997	578	470	540	788	567	631	502
Selling, General & Admin Expense	244	261	282	311	329	276	322	301	268	281	280
Marketing Expense	207	161	156	206	211	165	186	215	266	201	191
Research & Development Expense	34	32	33	35	38	29	32	32	33	31	31
Other Special Charges / (Income)	-	-	-	0.00	-	0.00	0.00	240	-	118	0.00
Total Other Income / (Expense), net	-54	-56	-19	-48	-47	-33	-190	-20	-42	1.00	1.00
Interest Expense	37	22	23	24	21	21	26	22	21	21	22
Other Income / (Expense), net	-17	-34	4.00	-24	-26	-12	-164	2.00	-21	22	23
Income Tax Expense	25	29	28	-36	56	4.00	40	8.00	54	74	43
Net Income / (Loss) Attributable to Noncontrolling Interest	3.00	2.00	3.00	2.00	5.00	3.00	3.00	1.00	5.00	4.00	1.00
Basic Earnings per Share	$0.82	$0.69	$0.81	($1.71)	$1.42	$0.17	$0.75	($0.41)	$1.75	$0.80	$1.55
Weighted Average Basic Shares Outstanding	123.11M	123.34M	123.55M	123.65M	123.59M	123.97M	124.18M	124.25M	124.17M	123.80M	123.77M
Diluted Earnings per Share	$0.82	$0.68	$0.80	($1.71)	$1.43	$0.17	$0.75	($0.41)	$1.74	$0.80	$1.54
Weighted Average Diluted Shares Outstanding	123.91M	123.91M	123.99M	123.65M	124.18M	124.65M	124.62M	124.25M	124.80M	124.68M	124.66M
Weighted Average Basic & Diluted Shares Outstanding	123.16M	123.38M	123.52M	123.62M	123.83M	124.06M	124.11M	124.19M	123.86M	123.78M	123.19M
Cash Dividends to Common per Share	$1.16	$2.36	$1.18	$1.18	-	$2.40	$1.20	$1.20	-	$2.44	$1.22

This table details how cash moves in and out of Clorox's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024
Net Change in Cash & Equivalents	53	19	14	-285	-21	766	-555	-138	182	-161
Net Cash From Operating Activities	874	778	865	976	992	1,546	1,276	786	1,158	695
Net Cash From Continuing Operating Activities	858	768	868	976	992	1,546	1,276	786	1,158	695
Net Income / (Loss) Continuing Operations	606	648	703	823	820	939	719	471	161	292
Consolidated Net Income / (Loss)	580	648	701	823	820	939	719	471	161	292
Depreciation Expense	169	165	163	166	180	180	211	224	236	235
Non-Cash Adjustments To Reconcile Net Income	-10	46	84	97	14	99	387	184	557	509
Changes in Operating Assets and Liabilities, net	93	-91	-82	-110	-22	328	-41	-93	204	-341
Net Cash From Investing Activities	-106	-430	-205	-859	-196	-252	-452	-229	-223	-175
Net Cash From Continuing Investing Activities	-106	-430	-205	-859	-196	-252	-452	-229	-223	-175
Purchase of Property, Plant & Equipment	-125	-172	-231	-194	-206	-254	-331	-251	-228	-212
Divestitures	-	-	-	-	-	-	-	0.00	0.00	17
Other Investing Activities, net	19	32	26	16	10	2.00	-36	22	5.00	20
Net Cash From Financing Activities	-696	-316	-645	-399	-815	-523	-1,391	-689	-753	-655
Net Cash From Continuing Financing Activities	-696	-316	-645	-399	-815	-523	-1,391	-689	-753	-655
Repayment of Debt	-623	-300	-125	-614	-	0.00	0.00	-1,405	0.00	0.00
Repurchase of Common Equity	-434	-254	-183	-271	-661	-248	-905	-25	0.00	0.00
Payment of Dividends	-385	-398	-412	-450	-490	-533	-589	-586	-598	-611
Issuance of Debt	495	426	0.00	891	189	96	0.00	1,322	-188	-45
Issuance of Common Equity	-	210	75	45	147	162	103	5.00	33	1.00
Effect of Exchange Rate Changes	-19	-13	-1.00	-3.00	-2.00	-5.00	12	-6.00	0.00	-26
Cash Interest Paid	104	79	78	75	87	89	89	89	99	102
Cash Income Taxes Paid	236	323	347	245	207	241	303	100	73	347

This table details how cash moves in and out of Clorox's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-57	94	-110	76	122	152	-162	-137	-14	75	12
Net Cash From Operating Activities	335	178	209	341	430	20	153	182	340	221	180
Net Cash From Continuing Operating Activities	335	178	209	341	430	20	153	182	340	221	180
Net Income / (Loss) Continuing Operations	104	87	102	-209	181	25	96	-50	221	103	194
Consolidated Net Income / (Loss)	104	87	102	-209	181	25	96	-50	221	103	194
Depreciation Expense	57	56	58	60	62	61	57	58	59	54	53
Non-Cash Adjustments To Reconcile Net Income	133	27	41	471	18	14	194	274	27	120	37
Changes in Operating Assets and Liabilities, net	41	8.00	8.00	19	169	-80	-194	-100	33	-56	-104
Net Cash From Investing Activities	-62	-45	-42	-55	-81	-23	-33	-38	-81	89	-54
Net Cash From Continuing Investing Activities	-62	-45	-42	-55	-81	-23	-33	-38	-81	89	-54
Purchase of Property, Plant & Equipment	-79	-46	-42	-56	-84	-24	-52	-55	-81	-39	-53
Other Investing Activities, net	17	1.00	-	1.00	3.00	1.00	19	-	-	0.00	-1.00
Net Cash From Financing Activities	-326	-35	-280	-211	-227	155	-259	-278	-273	-237	-109
Net Cash From Continuing Financing Activities	-326	-35	-280	-211	-227	155	-259	-278	-273	-237	-109
Repurchase of Common Equity	-	-	-	-	-	0.00	-	-	-	-107	-150
Payment of Dividends	-153	-145	-146	-146	-161	-149	-149	-148	-165	-151	-151
Issuance of Common Equity	5.00	-1.00	5.00	6.00	23	6.00	-7.00	4.00	-2.00	21	8.00
Effect of Exchange Rate Changes	-4.00	-4.00	3.00	1.00	-	0.00	-23	-3.00	-	2.00	-5.00

This table presents Clorox's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024
Total Assets	4,164	4,510	4,573	5,060	5,116	6,213	6,334	6,158	5,945	5,751
Total Current Assets	1,429	1,485	1,514	1,311	1,305	2,020	1,829	1,725	1,828	1,622
Cash & Equivalents	382	401	418	131	111	871	319	183	367	202
Accounts Receivable	519	569	565	600	631	648	604	681	688	695
Inventories, net	385	443	459	506	512	454	752	755	696	637
Prepaid Expenses	-	72	72	74	51	47	154	106	77	88
Plant, Property, & Equipment, net	918	906	931	996	1,034	1,103	1,302	1,334	1,345	1,315
Total Noncurrent Assets	1,817	2,119	2,128	2,753	2,777	3,090	3,203	3,099	2,772	2,814
Goodwill	1,067	1,197	1,196	1,602	1,591	1,577	1,575	1,558	1,252	1,228
Intangible Assets	585	735	722	929	912	894	918	884	712	681
Other Noncurrent Operating Assets	165	187	210	222	274	619	710	657	808	905
Total Liabilities & Shareholders' Equity	4,164	4,510	4,573	5,060	5,116	6,213	6,334	6,158	5,945	5,751
Total Liabilities	4,046	4,213	4,031	4,334	4,557	5,305	5,742	5,429	5,557	5,259
Total Current Liabilities	1,405	1,558	1,809	1,200	1,440	1,418	2,056	1,784	1,917	1,574
Short-Term Debt	395	523	804	199	396	0.00	300	237	50	4.00
Accounts Payable	979	1,035	1,005	1,001	1,035	1,329	1,675	1,469	1,659	1,486
Other Current Liabilities	-	-	-	-	0.00	64	81	78	87	84
Total Noncurrent Liabilities	2,641	2,655	2,222	3,134	3,117	3,887	3,686	3,645	3,640	3,685
Long-Term Debt	2,546	2,573	2,161	3,062	2,287	2,780	2,484	2,474	2,477	2,481
Noncurrent Deferred & Payable Income Tax Liabilities	95	82	61	72	50	62	67	66	28	22
Other Noncurrent Operating Liabilities	-	-	-	-	780	1,045	1,135	1,105	1,135	1,182
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	118	297	542	726	559	908	592	729	388	492
Total Preferred & Common Equity	118	297	542	726	559	908	411	556	220	328
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	118	297	542	726	559	908	411	556	220	328
Common Stock	934	1,027	1,087	1,134	1,205	1,296	1,317	1,333	1,376	1,419
Retained Earnings	1,923	2,163	2,440	2,797	3,150	3,567	1,036	1,048	583	250
Treasury Stock	-2,237	-2,323	-2,442	-2,658	-3,194	-3,315	-1,396	-1,346	-1,246	-1,186
Accumulated Other Comprehensive Income / (Loss)	-502	-570	-543	-547	-602	-640	-546	-479	-493	-155
Noncontrolling Interest	-	-	-	-	-	0.00	181	173	168	164

This table presents Clorox's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Total Assets	6,158	6,153	6,045	5,818	5,945	5,991	5,908	5,805	5,751	5,497	5,577
Total Current Assets	1,725	1,763	1,622	1,745	1,828	1,911	1,804	1,661	1,622	1,576	1,632
Cash & Equivalents	183	278	168	242	367	518	355	219	202	278	290
Accounts Receivable	681	612	600	678	688	581	679	673	695	595	603
Inventories, net	755	755	741	735	696	710	655	674	637	594	592
Prepaid Expenses	106	118	113	90	77	102	115	95	88	109	147
Plant, Property, & Equipment, net	1,334	1,322	1,322	1,315	1,345	1,317	1,314	1,292	1,315	1,242	1,242
Total Noncurrent Assets	3,099	3,068	3,101	2,758	2,772	2,763	2,790	2,852	2,814	2,679	2,703
Goodwill	1,558	1,546	1,553	1,250	1,252	1,246	1,252	1,229	1,228	1,233	1,219
Intangible Assets	884	875	868	722	712	703	698	688	681	581	574
Other Noncurrent Operating Assets	657	647	680	786	808	814	840	935	905	865	910
Total Liabilities & Shareholders' Equity	6,158	6,153	6,045	5,818	5,945	5,991	5,908	5,805	5,751	5,497	5,577
Total Liabilities	5,429	5,657	5,554	5,646	5,557	5,860	5,690	5,550	5,259	5,273	5,456
Total Current Liabilities	1,784	2,010	1,878	1,996	1,917	2,228	2,022	1,846	1,574	1,579	1,730
Short-Term Debt	237	348	209	138	50	347	247	111	4.00	4.00	189
Accounts Payable	1,469	1,584	1,589	1,722	1,659	1,678	1,649	1,653	1,486	1,472	1,460
Other Current Liabilities	78	78	80	88	87	88	92	82	84	83	81
Total Noncurrent Liabilities	3,645	3,647	3,676	3,650	3,640	3,632	3,668	3,704	3,685	3,694	3,726
Long-Term Debt	2,474	2,475	2,476	2,476	2,477	2,478	2,479	2,480	2,481	2,482	2,483
Noncurrent Deferred & Payable Income Tax Liabilities	66	59	56	27	28	27	26	24	22	23	22
Other Noncurrent Operating Liabilities	1,105	1,113	1,144	1,147	1,135	1,127	1,163	1,200	1,182	1,189	1,221
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	729	496	491	172	388	131	218	255	492	224	121
Total Preferred & Common Equity	556	326	321	3.00	220	-37	53	91	328	60	-41
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	556	326	321	3.00	220	-37	53	91	328	60	-41
Common Stock	1,333	1,324	1,338	1,363	1,376	1,377	1,376	1,401	1,419	1,428	1,418
Retained Earnings	1,048	832	782	415	583	299	241	34	250	31	68
Treasury Stock	-1,346	-1,315	-1,297	-1,277	-1,246	-1,219	-1,205	-1,189	-1,186	-1,252	-1,346
Accumulated Other Comprehensive Income / (Loss)	-479	-515	-502	-498	-493	-494	-359	-155	-155	-147	-181
Noncontrolling Interest	173	170	170	169	168	168	165	164	164	164	162

This table displays calculated financial ratios and metrics derived from Clorox's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.56%	1.87%	3.68%	2.53%	1.47%	8.16%	9.22%	-3.19%	3.97%	-4.01%
EBITDA Growth	2.34%	-78.78%	3.88%	1.64%	-0.31%	12.53%	-17.35%	-22.56%	-39.81%	28.19%
EBIT Growth	2.56%	-81.06%	4.67%	1.61%	-1.58%	14.54%	-22.20%	-28.63%	-54.00%	48.78%
NOPAT Growth	2.56%	-82.28%	9.35%	15.65%	1.47%	12.16%	-26.64%	-21.42%	-52.57%	81.56%
Net Income Growth	3.94%	11.72%	8.18%	17.40%	-0.36%	14.51%	-23.43%	-34.49%	-65.82%	81.37%
EPS Growth	0.00%	0.00%	8.33%	17.45%	0.96%	16.46%	-24.18%	-33.15%	-67.83%	87.50%
Operating Cash Flow Growth	13.95%	-10.98%	11.18%	12.83%	1.64%	55.85%	-17.46%	-38.40%	47.33%	-39.98%
Free Cash Flow Firm Growth	-13.23%	-88.70%	73.39%	-82.08%	1,253.91%	-18.56%	-62.18%	-23.69%	157.88%	-72.17%
Invested Capital Growth	25.21%	11.77%	3.24%	24.83%	-18.80%	-10.03%	8.52%	6.54%	-21.77%	8.91%
Revenue Q/Q Growth	1.07%	0.75%	0.79%	0.72%	-1.02%	5.59%	-2.41%	-0.01%	3.04%	-1.61%
EBITDA Q/Q Growth	2.21%	-79.09%	3.46%	1.24%	-0.84%	7.57%	-19.17%	4.81%	20.77%	5.09%
EBIT Q/Q Growth	2.33%	-81.36%	4.09%	1.15%	-1.15%	8.72%	-22.74%	5.94%	38.98%	8.44%
NOPAT Q/Q Growth	-12.45%	-81.69%	6.15%	1.87%	2.51%	5.33%	-19.47%	2.20%	39.13%	10.13%
Net Income Q/Q Growth	3.76%	-3.86%	5.41%	1.98%	3.02%	7.93%	-22.61%	0.86%	91.67%	15.87%
EPS Q/Q Growth	100.00%	564.86%	5.34%	2.29%	3.27%	8.24%	-22.28%	0.00%	103.39%	15.98%
Operating Cash Flow Q/Q Growth	5.05%	-5.81%	6.40%	1.77%	-1.10%	29.37%	-21.86%	-5.76%	8.94%	-11.47%
Free Cash Flow Firm Q/Q Growth	-27.00%	-89.96%	265.22%	-84.53%	755.06%	-27.18%	-38.63%	-34.31%	13.04%	-26.32%
Invested Capital Q/Q Growth	28.09%	44.33%	-3.50%	16.99%	-21.41%	-9.86%	-5.33%	1.24%	0.16%	5.63%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	43.59%	45.10%	44.72%	43.68%	43.90%	45.57%	43.58%	35.81%	39.36%	42.97%
EBITDA Margin	102.99%	21.45%	21.50%	21.31%	20.94%	21.78%	16.48%	13.18%	7.63%	10.19%
Operating Margin	100.00%	18.47%	18.87%	18.55%	18.09%	18.96%	12.63%	10.55%	5.52%	9.63%
EBIT Margin	100.00%	18.59%	18.77%	18.60%	18.04%	19.10%	13.61%	10.03%	4.44%	6.88%
Profit (Net Income) Margin	10.26%	11.25%	11.74%	13.44%	13.20%	13.97%	9.79%	6.63%	2.18%	4.12%
Tax Burden Percent	0.00%	65.92%	67.86%	78.08%	80.08%	79.24%	79.89%	77.59%	67.65%	73.37%
Interest Burden Percent	0.00%	91.78%	92.15%	92.54%	91.35%	92.29%	90.09%	85.13%	72.56%	81.56%
Effective Tax Rate	0.00%	34.08%	31.95%	21.92%	19.92%	20.76%	20.11%	22.41%	32.35%	26.63%
Return on Invested Capital (ROIC)	164.42%	24.75%	25.23%	25.54%	25.76%	33.95%	25.22%	18.43%	9.51%	18.83%
ROIC Less NNEP Spread (ROIC-NNEP)	15.69%	22.71%	22.71%	23.29%	22.96%	30.80%	24.23%	13.99%	4.60%	9.42%
Return on Net Nonoperating Assets (RNNOA)	262.05%	287.54%	141.88%	104.27%	101.86%	94.07%	70.65%	52.88%	19.32%	47.54%
Return on Equity (ROE)	426.47%	312.29%	167.10%	129.81%	127.63%	128.02%	95.87%	71.31%	28.83%	66.36%
Cash Return on Invested Capital (CROIC)	142.04%	13.63%	22.03%	3.46%	46.52%	44.50%	17.04%	12.10%	33.94%	10.30%
Operating Return on Assets (OROA)	134.29%	24.69%	24.68%	23.65%	22.03%	22.67%	15.92%	11.42%	5.42%	8.34%
Return on Assets (ROA)	13.77%	14.94%	15.44%	17.09%	16.12%	16.58%	11.46%	7.54%	2.66%	4.99%
Return on Common Equity (ROCE)	426.47%	312.29%	167.10%	129.81%	127.63%	128.02%	84.30%	52.20%	20.03%	41.33%
Return on Equity Simple (ROE_SIMPLE)	491.53%	218.18%	129.34%	113.36%	146.69%	103.41%	174.94%	84.71%	73.18%	89.02%
Net Operating Profit after Tax (NOPAT)	3,959	701	767	887	900	1,010	741	582	276	501
NOPAT Margin	70.00%	12.17%	12.84%	14.48%	14.48%	15.02%	10.09%	8.19%	3.74%	7.06%
Net Nonoperating Expense Percent (NNEP)	148.73%	2.03%	2.52%	2.26%	2.81%	3.15%	0.99%	4.44%	4.91%	9.41%
Cost of Revenue to Revenue	0.00%	54.90%	55.28%	56.32%	56.10%	54.43%	56.42%	64.19%	60.64%	57.03%
SG&A Expenses to Revenue	0.00%	13.99%	13.56%	13.67%	13.78%	14.42%	13.68%	13.42%	16.01%	16.45%
R&D to Revenue	0.00%	2.45%	2.26%	2.16%	2.19%	2.16%	2.03%	1.86%	1.87%	1.78%
Operating Expenses to Revenue	0.00%	26.63%	25.85%	25.13%	25.81%	26.62%	30.95%	25.26%	33.83%	33.34%
Earnings before Interest and Taxes (EBIT)	5,655	1,071	1,121	1,139	1,121	1,284	999	713	328	488
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	5,824	1,236	1,284	1,305	1,301	1,464	1,210	937	564	723
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	89.80	48.01	25.86	20.25	30.06	26.89	49.15	28.97	85.65	51.23
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.87	2.47	2.35	2.40	2.70	3.63	2.75	2.27	2.55	2.37
Price to Earnings (P/E)	1.88	22.00	20.00	17.86	20.49	26.01	28.45	34.86	126.46	60.01
Dividend Yield	3.66%	2.79%	2.94%	3.07%	2.91%	2.19%	2.73%	3.55%	3.10%	3.55%
Earnings Yield	53.12%	4.54%	5.00%	5.60%	4.88%	3.85%	3.51%	2.87%	0.79%	1.67%
Enterprise Value to Invested Capital (EV/IC)	4.91	5.67	5.36	4.62	6.19	9.35	7.47	5.77	8.31	6.94
Enterprise Value to Revenue (EV/Rev)	2.33	2.94	2.77	2.91	3.12	3.92	3.11	2.65	2.87	2.71
Enterprise Value to EBITDA (EV/EBITDA)	2.26	13.72	12.90	13.67	14.89	17.98	18.88	20.07	37.54	26.63
Enterprise Value to EBIT (EV/EBIT)	2.33	15.83	14.78	15.66	17.28	20.51	22.87	26.38	64.54	39.45
Enterprise Value to NOPAT (EV/NOPAT)	3.32	24.17	21.60	20.10	21.52	26.08	30.85	32.32	76.71	38.42
Enterprise Value to Operating Cash Flow (EV/OCF)	15.05	21.79	19.15	18.27	19.53	17.03	17.91	23.93	18.28	27.70
Enterprise Value to Free Cash Flow (EV/FCFF)	3.85	43.87	24.73	148.57	11.92	19.89	45.64	49.24	21.49	70.23
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	24.92	10.42	5.47	4.49	4.80	3.06	4.70	3.72	6.51	5.05
Long-Term Debt to Equity	21.58	8.66	3.99	4.22	4.09	3.06	4.20	3.39	6.38	5.04
Financial Leverage	16.70	12.66	6.25	4.48	4.44	3.05	2.92	3.78	4.20	5.05
Leverage Ratio	30.96	20.90	10.83	7.60	7.92	7.72	8.36	9.46	10.84	13.29
Compound Leverage Factor	0.00	19.18	9.98	7.03	7.23	7.13	7.54	8.05	7.86	10.84
Debt to Total Capital	96.14%	91.25%	84.55%	81.79%	82.76%	75.38%	82.46%	78.81%	86.69%	83.47%
Short-Term Debt to Total Capital	12.91%	15.41%	22.93%	4.99%	12.21%	0.00%	8.89%	6.89%	1.72%	0.13%
Long-Term Debt to Total Capital	83.23%	75.83%	61.62%	76.80%	70.54%	75.38%	73.58%	71.92%	84.97%	83.34%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	5.36%	5.03%	5.76%	5.51%
Common Equity to Total Capital	3.86%	8.75%	15.45%	18.21%	17.24%	24.62%	12.17%	16.16%	7.55%	11.02%
Debt to EBITDA	0.51	2.50	2.31	2.50	2.06	1.90	2.30	2.89	4.48	3.44
Net Debt to EBITDA	0.44	2.18	1.98	2.40	1.98	1.30	2.04	2.70	3.83	3.16
Long-Term Debt to EBITDA	0.44	2.08	1.68	2.35	1.76	1.90	2.05	2.64	4.39	3.43
Debt to NOPAT	0.74	4.41	3.87	3.68	2.98	2.75	3.76	4.66	9.16	4.96
Net Debt to NOPAT	0.65	3.84	3.32	3.53	2.86	1.89	3.33	4.34	7.83	4.56
Long-Term Debt to NOPAT	0.64	3.67	2.82	3.45	2.54	2.75	3.35	4.25	8.97	4.95
Altman Z-Score	8.06	4.74	4.87	4.79	4.98	5.45	3.98	3.54	3.58	3.50
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	12.07%	26.80%	30.53%	37.73%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.02	0.95	0.84	1.09	0.91	1.42	0.89	0.97	0.95	1.03
Quick Ratio	0.64	0.62	0.54	0.61	0.52	1.07	0.45	0.48	0.55	0.57
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	3,420	386	670	120	1,625	1,324	501	382	985	274
Operating Cash Flow to CapEx	699.20%	452.33%	374.46%	503.09%	481.55%	608.66%	385.50%	313.15%	507.89%	327.83%
Free Cash Flow to Firm to Interest Expense	0.00	4.39	7.61	1.41	16.75	13.37	5.06	3.60	10.94	3.05
Operating Cash Flow to Interest Expense	0.00	8.84	9.83	11.48	10.23	15.62	12.89	7.42	12.87	7.72
Operating Cash Flow Less CapEx to Interest Expense	0.00	6.89	7.20	9.20	8.10	13.05	9.55	5.05	10.33	5.37
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.34	1.33	1.32	1.27	1.22	1.19	1.17	1.14	1.22	1.21
Accounts Receivable Turnover	10.62	10.59	10.53	10.51	10.10	10.51	11.73	11.06	10.79	10.26
Inventory Turnover	0.00	7.64	7.32	7.15	6.85	7.57	6.87	6.05	6.18	6.07
Fixed Asset Turnover	5.97	6.32	6.50	6.36	6.12	6.29	6.10	5.39	5.52	5.33
Accounts Payable Turnover	0.00	3.14	3.24	3.44	3.42	3.09	2.76	2.90	2.87	2.57
Days Sales Outstanding (DSO)	34.37	34.47	34.65	34.72	36.15	34.73	31.13	33.00	33.81	35.58
Days Inventory Outstanding (DIO)	0.00	47.77	49.85	51.06	53.29	48.19	53.14	60.29	59.10	60.14
Days Payable Outstanding (DPO)	0.00	116.20	112.75	106.15	106.59	117.94	132.36	125.77	127.40	141.89
Cash Conversion Cycle (CCC)	34.37	-33.96	-28.25	-20.37	-17.14	-35.02	-48.10	-32.49	-34.49	-46.17
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,677	2,992	3,089	3,856	3,131	2,817	3,057	3,257	2,548	2,775
Invested Capital Turnover	2.35	2.03	1.96	1.76	1.78	2.26	2.50	2.25	2.55	2.67
Increase / (Decrease) in Invested Capital	539	315	97	767	-725	-314	240	200	-709	227
Enterprise Value (EV)	13,155	16,953	16,566	17,833	19,373	26,329	22,847	18,806	21,171	19,251
Market Capitalization	10,596	14,258	14,019	14,703	16,801	24,420	20,201	16,105	18,843	16,804
Book Value per Share	$0.90	$2.30	$4.21	$5.61	$4.39	$7.21	$3.30	$4.52	$1.78	$2.64
Tangible Book Value per Share	($11.69)	($12.64)	($10.68)	($13.94)	($15.26)	($12.41)	($16.74)	($15.32)	($14.11)	($12.73)
Total Capital	3,059	3,393	3,507	3,987	3,242	3,688	3,376	3,440	2,915	2,977
Total Debt	2,941	3,096	2,965	3,261	2,683	2,780	2,784	2,711	2,527	2,485
Total Long-Term Debt	2,546	2,573	2,161	3,062	2,287	2,780	2,484	2,474	2,477	2,481
Net Debt	2,559	2,695	2,547	3,130	2,572	1,909	2,465	2,528	2,160	2,283
Capital Expenditures (CapEx)	125	172	231	194	206	254	331	251	228	212
Debt-free, Cash-free Net Working Capital (DFCFNWC)	37	49	91	179	150	-269	-246	-5.00	-406	-150
Debt-free Net Working Capital (DFNWC)	419	450	509	310	261	602	73	178	-39	52
Net Working Capital (NWC)	24	-73	-295	111	-135	602	-227	-59	-89	48
Net Nonoperating Expense (NNE)	3,379	53	66	64	80	71	22	111	115	209
Net Nonoperating Obligations (NNO)	2,559	2,695	2,547	3,130	2,572	1,909	2,465	2,528	2,160	2,283
Total Depreciation and Amortization (D&A)	169	165	163	166	180	180	211	224	236	235
Debt-free, Cash-free Net Working Capital to Revenue	0.65%	0.85%	1.52%	2.92%	2.41%	-4.00%	-3.35%	-0.07%	-5.49%	-2.11%
Debt-free Net Working Capital to Revenue	7.41%	7.81%	8.52%	5.06%	4.20%	8.96%	0.99%	2.50%	-0.53%	0.73%
Net Working Capital to Revenue	0.42%	-1.27%	-4.94%	1.81%	-2.17%	8.96%	-3.09%	-0.83%	-1.20%	0.68%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.45	$5.01	$0.00	$0.00	$6.42	$7.46	$5.66	$3.75	$1.21	$2.26
Adjusted Weighted Average Basic Shares Outstanding	130.31M	129.47M	0.00	0.00	127.73M	125.83M	125.57M	123.11M	123.59M	124.17M
Adjusted Diluted Earnings per Share	$4.37	$4.92	$0.00	$0.00	$6.32	$7.36	$5.58	$3.73	$1.20	$2.25
Adjusted Weighted Average Diluted Shares Outstanding	132.78M	131.72M	0.00	0.00	129.79M	127.67M	127.30M	123.91M	124.18M	124.80M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	128.64M	129.47M	0.00	0.00	125.74M	126.21M	122.81M	123.16M	123.83M	123.86M
Normalized Net Operating Profit after Tax (NOPAT)	3,959	701	767	887	900	1,010	1,003	582	577	677
Normalized NOPAT Margin	70.00%	12.17%	12.84%	14.48%	14.48%	15.02%	13.67%	8.19%	7.81%	9.55%
Pre Tax Income Margin	0.00%	17.06%	17.29%	17.21%	16.48%	17.63%	12.26%	8.54%	3.22%	5.61%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	12.17	12.74	13.40	11.56	12.97	10.09	6.73	3.64	5.42
NOPAT to Interest Expense	0.00	7.97	8.72	10.44	9.28	10.20	7.48	5.49	3.07	5.57
EBIT Less CapEx to Interest Expense	0.00	10.22	10.11	11.12	9.43	10.40	6.75	4.36	1.11	3.07
NOPAT Less CapEx to Interest Expense	0.00	6.02	6.09	8.15	7.16	7.63	4.14	3.12	0.53	3.21
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	66.38%	61.42%	58.77%	54.68%	59.76%	56.76%	81.92%	124.42%	371.43%	209.25%
Augmented Payout Ratio	141.21%	100.62%	84.88%	87.61%	140.37%	83.17%	207.79%	129.72%	371.43%	209.25%

This table displays calculated financial ratios and metrics derived from Clorox's official financial filings.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.06%	-3.65%	1.42%	5.86%	12.10%	-20.34%	16.04%	-5.27%	-5.75%	27.13%	-15.28%
EBITDA Growth	23.89%	-26.79%	23.39%	-157.91%	43.50%	-42.78%	3.79%	123.60%	10.94%	127.03%	42.47%
EBIT Growth	31.75%	-34.29%	31.90%	-200.00%	55.42%	-63.77%	5.88%	90.95%	14.73%	296.00%	59.88%
NOPAT Growth	7.20%	-23.80%	30.18%	-178.21%	47.01%	-58.57%	96.84%	88.83%	17.45%	91.62%	-16.05%
Net Income Growth	4.00%	-39.16%	41.67%	-237.50%	74.04%	-71.26%	-5.88%	76.08%	22.10%	312.00%	102.08%
EPS Growth	0.00%	-40.35%	42.86%	-241.32%	74.39%	-75.00%	-6.25%	76.02%	21.68%	370.59%	105.33%
Operating Cash Flow Growth	-12.53%	334.15%	15.47%	48.91%	28.36%	-88.76%	-26.79%	-46.63%	-20.93%	1,005.00%	17.65%
Free Cash Flow Firm Growth	48.75%	51.84%	-21.51%	184.14%	1,864.78%	122.52%	134.42%	-118.39%	-97.00%	-83.48%	-56.99%
Invested Capital Growth	6.54%	-5.18%	-5.05%	-20.92%	-21.77%	-19.83%	-13.93%	3.26%	8.91%	-0.25%	-3.32%
Revenue Q/Q Growth	-0.44%	-3.39%	-1.44%	11.66%	5.43%	-31.35%	43.58%	-8.84%	4.91%	-7.41%	-4.31%
EBITDA Q/Q Growth	-19.78%	-13.00%	8.76%	-176.30%	298.76%	-65.31%	97.30%	-82.65%	834.21%	-29.01%	23.81%
EBIT Q/Q Growth	-24.89%	-16.87%	10.87%	-244.44%	216.74%	-80.62%	224.00%	-112.35%	1,580.00%	-33.11%	30.81%
NOPAT Q/Q Growth	-16.33%	-12.56%	-9.37%	-217.96%	257.28%	-75.36%	330.54%	-106.69%	1,754.24%	-59.80%	88.62%
Net Income Q/Q Growth	-31.58%	-16.35%	17.24%	-304.90%	186.60%	-86.19%	284.00%	-152.08%	542.00%	-53.39%	88.35%
EPS Q/Q Growth	-32.23%	-17.07%	17.65%	-313.75%	183.63%	-88.11%	341.18%	-154.67%	524.39%	-54.02%	92.50%
Operating Cash Flow Q/Q Growth	46.29%	-46.87%	17.42%	63.16%	26.10%	-95.35%	665.00%	18.95%	86.81%	-35.00%	-18.55%
Free Cash Flow Firm Q/Q Growth	-127.86%	662.28%	-6.13%	93.24%	73.03%	-29.10%	-1.12%	-115.16%	128.20%	290.66%	157.50%
Invested Capital Q/Q Growth	1.24%	-6.63%	-1.09%	-15.43%	0.16%	-4.32%	6.19%	1.47%	5.63%	-12.36%	2.92%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	37.09%	35.98%	36.15%	41.78%	42.69%	38.38%	43.52%	42.23%	46.45%	45.80%	43.77%
EBITDA Margin	12.38%	11.15%	12.30%	-8.41%	15.85%	8.01%	11.01%	2.09%	18.65%	14.30%	18.51%
Operating Margin	10.16%	9.89%	8.69%	-10.29%	14.07%	4.47%	16.38%	-1.21%	16.66%	9.99%	14.00%
EBIT Margin	9.22%	7.93%	8.92%	-11.54%	12.78%	3.61%	8.14%	-1.10%	15.55%	11.24%	15.36%
Profit (Net Income) Margin	5.77%	5.00%	5.95%	-10.91%	8.96%	1.80%	4.82%	-2.76%	11.61%	5.85%	11.51%
Tax Burden Percent	80.62%	75.00%	78.46%	85.31%	76.37%	86.21%	70.59%	119.05%	80.36%	58.19%	81.86%
Interest Burden Percent	77.71%	84.06%	84.97%	110.86%	91.86%	58.00%	83.95%	210.00%	92.91%	89.39%	91.51%
Effective Tax Rate	19.38%	25.00%	21.54%	0.00%	23.63%	13.79%	29.41%	0.00%	19.64%	41.81%	18.14%
Return on Invested Capital (ROIC)	18.44%	16.71%	15.60%	-17.93%	27.35%	9.90%	30.21%	-2.37%	35.68%	17.83%	32.25%
ROIC Less NNEP Spread (ROIC-NNEP)	16.70%	15.10%	15.02%	-20.76%	25.82%	8.73%	24.72%	-3.83%	34.16%	17.86%	32.28%
Return on Net Nonoperating Assets (RNNOA)	63.11%	75.33%	79.45%	-139.16%	108.35%	67.56%	170.41%	-42.50%	172.46%	227.09%	452.58%
Return on Equity (ROE)	81.55%	92.04%	95.05%	-157.08%	135.70%	77.46%	200.62%	-44.87%	208.13%	244.92%	484.83%
Cash Return on Invested Capital (CROIC)	12.10%	22.67%	23.63%	30.25%	33.94%	29.14%	25.03%	14.39%	10.30%	22.43%	23.46%
Operating Return on Assets (OROA)	10.49%	8.99%	10.30%	-13.63%	15.60%	4.18%	9.96%	-1.37%	18.87%	14.61%	19.17%
Return on Assets (ROA)	6.57%	5.67%	6.87%	-12.89%	10.95%	2.09%	5.90%	-3.42%	14.09%	7.60%	14.36%
Return on Common Equity (ROCE)	59.70%	61.24%	61.37%	-84.63%	94.27%	35.70%	105.83%	-9.88%	129.61%	15.87%	17.16%
Return on Equity Simple (ROE_SIMPLE)	0.00%	127.30%	138.63%	2,800.00%	0.00%	-267.57%	175.47%	276.92%	0.00%	616.67%	-1,141.46%
Net Operating Profit after Tax (NOPAT)	148	129	117	-138	217	53	230	-15	255	102	193
NOPAT Margin	8.19%	7.41%	6.82%	-7.20%	10.74%	3.86%	11.56%	-0.85%	13.39%	5.81%	11.46%
Net Nonoperating Expense Percent (NNEP)	1.74%	1.61%	0.57%	2.84%	1.53%	1.17%	5.49%	1.46%	1.52%	-0.03%	-0.03%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	7.82%	-	-	-	6.92%
Cost of Revenue to Revenue	62.91%	64.02%	63.85%	58.22%	57.31%	61.62%	56.48%	57.77%	53.55%	54.20%	56.23%
SG&A Expenses to Revenue	13.55%	15.00%	16.44%	16.24%	16.30%	19.91%	16.18%	16.59%	14.08%	15.95%	16.61%
R&D to Revenue	1.89%	1.84%	1.92%	1.83%	1.88%	2.09%	1.61%	1.76%	1.73%	1.76%	1.84%
Operating Expenses to Revenue	26.93%	26.09%	27.46%	52.06%	28.63%	33.91%	27.14%	43.44%	29.80%	35.81%	29.77%
Earnings before Interest and Taxes (EBIT)	166	138	153	-221	258	50	162	-20	296	198	259
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	223	194	211	-161	320	111	219	38	355	252	312
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	28.97	45.38	50.90	6,199.72	85.65	0.00	320.47	205.33	51.23	333.73	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.27	2.10	2.31	2.59	2.55	2.21	2.32	2.59	2.37	2.68	2.78
Price to Earnings (P/E)	34.86	36.53	37.56	251.34	126.46	180.79	212.31	77.85	60.01	56.09	43.65
Dividend Yield	3.55%	3.88%	3.53%	3.12%	3.10%	3.78%	3.48%	3.17%	3.55%	2.98%	3.00%
Earnings Yield	2.87%	2.74%	2.66%	0.40%	0.79%	0.55%	0.47%	1.28%	1.67%	1.78%	2.29%
Enterprise Value to Invested Capital (EV/IC)	5.77	5.76	6.33	8.31	8.31	7.39	7.54	8.08	6.94	9.21	8.99
Enterprise Value to Revenue (EV/Rev)	2.65	2.49	2.69	2.95	2.87	2.56	2.67	2.94	2.71	3.00	3.14
Enterprise Value to EBITDA (EV/EBITDA)	20.07	20.22	21.00	45.27	37.54	37.47	39.92	30.84	26.63	25.92	23.50
Enterprise Value to EBIT (EV/EBIT)	26.38	27.32	28.06	89.58	64.54	75.10	78.40	47.16	39.45	35.21	30.69
Enterprise Value to NOPAT (EV/NOPAT)	32.32	32.29	33.40	106.57	76.71	92.25	69.38	46.64	38.42	41.47	43.98
Enterprise Value to Operating Cash Flow (EV/OCF)	23.93	18.97	20.01	19.89	18.28	18.02	20.68	27.03	27.70	25.00	24.37
Enterprise Value to Free Cash Flow (EV/FCFF)	49.24	24.72	26.08	24.26	21.49	22.57	27.87	57.05	70.23	41.01	37.65
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	3.72	5.69	5.47	15.20	6.51	21.56	12.50	10.16	5.05	11.10	22.08
Long-Term Debt to Equity	3.39	4.99	5.04	14.40	6.38	18.92	11.37	9.73	5.04	11.08	20.52
Financial Leverage	3.78	4.99	5.29	6.70	4.20	7.74	6.89	11.11	5.05	12.72	14.02
Leverage Ratio	9.46	11.91	12.46	16.23	10.84	19.37	16.86	27.22	13.29	32.36	33.88
Compound Leverage Factor	7.35	10.02	10.59	17.99	9.95	11.23	14.15	57.16	12.35	28.93	31.00
Debt to Total Capital	78.81%	85.06%	84.54%	93.83%	86.69%	95.57%	92.60%	91.04%	83.47%	91.73%	95.67%
Short-Term Debt to Total Capital	6.89%	10.49%	6.58%	4.95%	1.72%	11.74%	8.39%	3.90%	0.13%	0.15%	6.77%
Long-Term Debt to Total Capital	71.92%	74.57%	77.96%	88.87%	84.97%	83.83%	84.21%	87.14%	83.34%	91.59%	88.90%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	5.03%	5.12%	5.35%	6.07%	5.76%	5.68%	5.60%	5.76%	5.51%	6.05%	5.80%
Common Equity to Total Capital	16.16%	9.82%	10.11%	0.11%	7.55%	-1.25%	1.80%	3.20%	11.02%	2.21%	-1.47%
Debt to EBITDA	2.89	3.26	2.96	5.60	4.48	5.87	5.57	3.77	3.44	2.88	2.79
Net Debt to EBITDA	2.70	2.94	2.78	5.08	3.83	4.80	4.85	3.45	3.16	2.56	2.49
Long-Term Debt to EBITDA	2.64	2.86	2.73	5.30	4.39	5.15	5.07	3.60	3.43	2.87	2.59
Debt to NOPAT	4.66	5.21	4.71	13.18	9.16	14.46	9.69	5.69	4.96	4.60	5.22
Net Debt to NOPAT	4.34	4.69	4.42	11.96	7.83	11.81	8.43	5.21	4.56	4.09	4.66
Long-Term Debt to NOPAT	4.25	4.56	4.35	12.48	8.97	12.68	8.81	5.45	4.95	4.60	4.86
Altman Z-Score	3.25	2.93	3.15	3.13	3.54	2.80	3.13	3.22	3.39	3.76	3.63
Noncontrolling Interest Sharing Ratio	26.80%	33.46%	35.44%	46.12%	30.53%	53.91%	47.25%	77.99%	37.73%	93.52%	96.46%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.97	0.88	0.86	0.87	0.95	0.86	0.89	0.90	1.03	1.00	0.94
Quick Ratio	0.48	0.44	0.41	0.46	0.55	0.49	0.51	0.48	0.57	0.55	0.52
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-52	295	277	535	926	656	649	-98	28	108	279
Operating Cash Flow to CapEx	424.05%	386.96%	497.62%	608.93%	511.90%	83.33%	294.23%	330.91%	419.75%	566.67%	339.62%
Free Cash Flow to Firm to Interest Expense	-1.42	13.41	12.04	22.30	44.09	31.26	24.97	-4.47	1.32	5.16	12.69
Operating Cash Flow to Interest Expense	9.05	8.09	9.09	14.21	20.48	0.95	5.88	8.27	16.19	10.52	8.18
Operating Cash Flow Less CapEx to Interest Expense	6.92	6.00	7.26	11.88	16.48	-0.19	3.88	5.77	12.33	8.67	5.77
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.14	1.13	1.15	1.18	1.22	1.16	1.22	1.24	1.21	1.30	1.25
Accounts Receivable Turnover	11.06	11.12	12.09	10.72	10.79	11.79	11.43	10.67	10.26	12.70	11.18
Inventory Turnover	6.05	5.90	5.78	5.80	6.18	5.76	6.09	5.94	6.07	6.36	6.37
Fixed Asset Turnover	5.39	5.37	5.39	5.46	5.52	5.33	5.55	5.53	5.33	5.84	5.61
Accounts Payable Turnover	2.90	2.87	2.88	2.70	2.87	2.59	2.63	2.48	2.57	2.63	2.55
Days Sales Outstanding (DSO)	33.00	32.81	30.20	34.05	33.81	30.95	31.93	34.20	35.58	28.73	32.65
Days Inventory Outstanding (DIO)	60.29	61.91	63.20	62.98	59.10	63.34	59.95	61.47	60.14	57.40	57.32
Days Payable Outstanding (DPO)	125.77	127.27	126.84	135.00	127.40	141.04	139.04	147.25	141.89	138.66	142.92
Cash Conversion Cycle (CCC)	-32.49	-32.55	-33.45	-37.97	-34.49	-46.75	-47.17	-51.57	-46.17	-52.52	-52.94
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,257	3,041	3,008	2,544	2,548	2,438	2,589	2,627	2,775	2,432	2,503
Invested Capital Turnover	2.25	2.25	2.29	2.49	2.55	2.57	2.61	2.79	2.67	3.07	2.81
Increase / (Decrease) in Invested Capital	200	-166	-160	-673	-709	-603	-419	83	227	-6.00	-86
Enterprise Value (EV)	18,806	17,510	19,026	21,140	21,171	18,023	19,521	21,221	19,251	22,396	22,494
Market Capitalization	16,105	14,795	16,339	18,599	18,843	15,548	16,985	18,685	16,804	20,024	19,950
Book Value per Share	$4.52	$2.65	$2.60	$0.02	$1.78	($0.30)	$0.43	$0.73	$2.64	$0.48	($0.33)
Tangible Book Value per Share	($15.32)	($17.01)	($17.02)	($15.94)	($14.11)	($16.04)	($15.29)	($14.71)	($12.73)	($14.16)	($14.82)
Total Capital	3,440	3,319	3,176	2,786	2,915	2,956	2,944	2,846	2,977	2,710	2,793
Total Debt	2,711	2,823	2,685	2,614	2,527	2,825	2,726	2,591	2,485	2,486	2,672
Total Long-Term Debt	2,474	2,475	2,476	2,476	2,477	2,478	2,479	2,480	2,481	2,482	2,483
Net Debt	2,528	2,545	2,517	2,372	2,160	2,307	2,371	2,372	2,283	2,208	2,382
Capital Expenditures (CapEx)	79	46	42	56	84	24	52	55	81	39	53
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-5.00	-177	-215	-355	-406	-488	-326	-293	-150	-277	-199
Debt-free Net Working Capital (DFNWC)	178	101	-47	-113	-39	30	29	-74	52	1.00	91
Net Working Capital (NWC)	-59	-247	-256	-251	-89	-317	-218	-185	48	-3.00	-98
Net Nonoperating Expense (NNE)	44	42	15	71	36	28	134	35	34	-0.58	-0.82
Net Nonoperating Obligations (NNO)	2,528	2,545	2,517	2,372	2,160	2,307	2,371	2,372	2,283	2,208	2,382
Total Depreciation and Amortization (D&A)	57	56	58	60	62	61	57	58	59	54	53
Debt-free, Cash-free Net Working Capital to Revenue	-0.07%	-2.51%	-3.04%	-4.95%	-5.49%	-6.94%	-4.46%	-4.06%	-2.11%	-3.71%	-2.78%
Debt-free Net Working Capital to Revenue	2.50%	1.43%	-0.67%	-1.58%	-0.53%	0.43%	0.40%	-1.03%	0.73%	0.01%	1.27%
Net Working Capital to Revenue	-0.83%	-3.51%	-3.62%	-3.50%	-1.20%	-4.51%	-2.98%	-2.57%	0.68%	-0.04%	-1.37%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.82	$0.69	$0.81	($1.71)	$1.42	$0.17	$0.75	($0.41)	$1.75	$0.80	$1.55
Adjusted Weighted Average Basic Shares Outstanding	123.11M	123.34M	123.55M	123.65M	123.59M	123.97M	124.18M	124.25M	124.17M	123.80M	123.77M
Adjusted Diluted Earnings per Share	$0.82	$0.68	$0.80	($1.71)	$1.43	$0.17	$0.75	($0.41)	$1.74	$0.80	$1.54
Adjusted Weighted Average Diluted Shares Outstanding	123.91M	123.91M	123.99M	123.65M	124.18M	124.65M	124.62M	124.25M	124.80M	124.68M	124.66M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	123.16M	123.38M	123.52M	123.62M	123.83M	124.06M	124.11M	124.19M	123.86M	123.78M	123.19M
Normalized Net Operating Profit after Tax (NOPAT)	148	129	117	174	217	53	230	153	255	171	193
Normalized NOPAT Margin	8.19%	7.41%	6.82%	9.07%	10.74%	3.86%	11.56%	8.41%	13.39%	9.71%	11.46%
Pre Tax Income Margin	7.16%	6.67%	7.58%	-12.79%	11.74%	2.09%	6.83%	-2.32%	14.45%	10.05%	14.06%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.49	6.27	6.65	-9.21	12.29	2.38	6.23	-0.91	14.10	9.43	11.77
NOPAT to Interest Expense	3.99	5.86	5.08	-5.75	10.33	2.55	8.85	-0.70	12.13	4.88	8.78
EBIT Less CapEx to Interest Expense	2.35	4.18	4.83	-11.54	8.29	1.24	4.23	-3.41	10.24	7.57	9.36
NOPAT Less CapEx to Interest Expense	1.85	3.77	3.26	-8.08	6.33	1.40	6.85	-3.20	8.27	3.02	6.37
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	124.42%	141.93%	131.91%	702.38%	371.43%	608.08%	650.54%	240.87%	209.25%	165.68%	131.41%
Augmented Payout Ratio	129.72%	141.93%	131.91%	702.38%	371.43%	608.08%	650.54%	240.87%	209.25%	194.59%	186.32%

Frequently Asked Questions About Clorox's Financials

When does Clorox's financial year end?

According to the most recent income statement we have on file, Clorox's fiscal year ends in June. Their fiscal year 2024 ended on June 30, 2024.

How has Clorox's net income changed over the last 9 years?

Clorox's net income appears to be on a downward trend, with a most recent value of $292 million in 2024, falling from $580 million in 2015. The previous period was $161 million in 2023. See where experts think Clorox is headed by visiting Clorox's forecast page.

What is Clorox's operating income?

Clorox's total operating income in 2024 was $683 million, based on the following breakdown:

Total Gross Profit: $3.05 billion
Total Operating Expenses: $2.37 billion

How has Clorox revenue changed over the last 9 years?

Over the last 9 years, Clorox's total revenue changed from $5.66 billion in 2015 to $7.09 billion in 2024, a change of 25.4%.

How much debt does Clorox have?

Clorox's total liabilities were at $5.26 billion at the end of 2024, a 5.4% decrease from 2023, and a 30.0% increase since 2015.

How much cash does Clorox have?

In the past 9 years, Clorox's cash and equivalents has ranged from $111 million in 2019 to $871 million in 2020, and is currently $202 million as of their latest financial filing in 2024.

How has Clorox's book value per share changed over the last 9 years?

Over the last 9 years, Clorox's book value per share changed from 0.90 in 2015 to 2.64 in 2024, a change of 193.6%.

Related Companies

This page (NYSE:CLX) was last updated on 5/6/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Clorox (CLX) Financials

Frequently Asked Questions About Clorox's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Clorox (CLX) Financials

Annual Income Statements for Clorox

Quarterly Income Statements for Clorox

Annual Cash Flow Statements for Clorox

Quarterly Cash Flow Statements for Clorox

Annual Balance Sheets for Clorox

Quarterly Balance Sheets for Clorox

Annual Metrics and Ratios for Clorox

Quarterly Metrics and Ratios for Clorox

Frequently Asked Questions About Clorox's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools